Asthma UK Annual General Meeting 3 July 2018 Agenda Presentations - - PowerPoint PPT Presentation

Annual General Meeting 3 July 2018

Asthma UK

Agenda

Presentations ▪ Review of 2016 – 17 ▪ Digital Health ▪ Individual Giving ▪ Financial review Formal AGM business ▪ Apologies ▪ Minutes from 2017 AGM ▪ Annual Report ▪ Auditors ▪ Trustees

Highlights of 2016 - 17

Kay Boycott Chief Executive

Our mission: Stop asthma attacks. Cure asthma.

CAMPAIGN FOR CHANGE ON THE ISSUES THAT AFFECT PEOPLE WITH ASTHMA

We constantly challenge complacency around asthma so that everyone knows just how serious asthma is We campaign and raise awareness of the issues and solutions so everyone gets the right basic care that research has proved substantially reduces the risk of an asthma attack We help people with asthma speak directly to politicians and decision makers on the issues that are important to them

FUND WORLD-CLASS RESEARCH

We have invested over £50 million in asthma research to date We fund scientists to pursue new avenues of research into asthma and develop better treatments New technologies and better collaboration will increase the chances of scientific breakthroughs. Ultimately a cure that would transform the lives of people with asthma will be found We are determined that everyone with asthma will benefit from scientific breakthroughs

PROVIDE EXPERT ADVICE AND SUPPORT

We help people to effectively manage their daily life with asthma We achieve this by providing access to the best information and practical advice available through

• ur website and our expert asthma nurse helpline

How we are making a difference: In the last year, Asthma UK has…

➢ Supported over 1.8 million users on our website – an increase of 27% from last year ➢ Enabled 93,000 Asthma Action Plans to be downloaded – 71,000 of these for adults and 21,000 for children ➢ Selected as 1 of 4 ‘launch’ charities to use Facebook Pay ➢ Made the most from every donation: for every £1 spent…. 31.5p was reinvested in fundraising to make another £1 and 68.5p was spent on charitable activity ➢ Grown our social media channels by 20% (based year on year) ➢ Engaged with 30,000 Facebook users as part of our ‘back to school campaign’ and our pollen campaign reached 300,000 on social channels ➢ Helped 7367 people through our helpline whilst our nurses answered 7000 calls….at the same time as delivering popular asthma Q&A sessions on social media! ➢ Published the Annual Asthma Survey 2017, with 7611 responses – the largest AUK has ever seen! ➢ Successfully campaigned for the use of Mepolizumab and Reslizumab in the NHS ➢ Launched our Smart Asthma report as well as the 2016 – 2021 Research Strategy and the Research Roadmap ➢ Renewed our investment in the Basic Centre for another 5 years ➢ Funded 2 Fellows at Imperial College ➢ Co-funded £100,000 into the Epigenetics project (in partnership with LifeArc)

Research: ‘stand on the shoulders of giants’

2016 – 17 advances in scientific knowledge (funded through AUK research)

Dr Henry McSorley has uncovered novel means to target a cytokine called IL-33, which is strongly implicated in causing asthma; this discovery promises exciting new opportunities for intervention in asthma Dr Anna Furmanski tested the idea of controlling the amount of Hedgehog (Hh) proteins (which cause inflammation in the lungs) to minimise allergic immune responses in asthma; a promising new idea for potential asthma treatments

• Prof. Ian Sayers and his team have identified the main genetic changes in the IL-33 and ST-

2 genes that are relevant to asthma; paving the way to understanding the changes and targeting them for therapy to correct the change

• Prof. Salman Siddiqui has found different types of asthma pathology using new data

analysis techniques, allowing them to separate different types of airways pathology for people with mild, moderate and severe asthma Dr Hans Michael Haitchi (researching ADAM-33 a susceptibility gene that is associated with asthma) and his team have studied the effects caused by changes in ADAM-33 very early in life; leading to discoveries about the ways in which airways are prone to developing asthma when exposed to house dust mite allergen, at a very early stage in life

2016 – 17 advances in scientific knowledge (funded through AUK research)

Dr Rachel Clifford has identified several genes that are particularly interesting in airway muscle cells & examined these for changes in DNA and gene signalling Dr Amanda Tatler and the team have developed methods to perform key experiments on human tissue to compare responses between asthmatic and non-asthmatic breathing

• Prof. Hannah Gould and her team compared the gene expression signatures (which genes are ‘on’ and

which are ‘off’) of cells that produce IgE antibodies; leading to potential new discoveries for targeting intervention in the development and progression of asthma Dr Tara Sutherland has succeeded in establishing a ‘mouse model’ of allergic inflammation and the factors assumed to play a role in humans; future work will look at changes in lung structure Dr Hannah Durrington has continued her work on understanding why asthma varies so much

• ver the course of a day, this data has been presented as a talk at the European Biological

Rhythms Society meeting (July 2017)

• Prof. Andrew Wardlaw and his Asthma UK funded PhD student have continued their work

exploring the relationship between fungal allergy and lung damage. Their results could have major implications for treating fungal allergy in asthma

Delivering charitable purpose Managing resources responsibly Activity 2017 – 2020 Strategy Activity 2017 – 2020 Strategy Improve asthma management wherever delivered Inspire people with asthma to make a positive change Maximise resources for the long-term benefit of people with asthma Develop a sustainable asthma income generation model for a digital world Re-imagine asthma self-management through digital innovation Pursue improvement in the NHS for people with asthma Speed up research against the biggest asthma priorities Broker ambitious research collaborations Advance Asthma UK’s agility and productivity Invest in exceptional patient-centric science

Asthma UK 2017 – 2020: strategy

Digital health

Emma Rubach Advice & Content Manager, Digital Health

Our risk checker engaged new people

Cross-selling the risk checker with our lottery audience has proved successful. After completing the checker people also have the option to sign up to get more email advice from us. 50% increase in people using the risk checker tool

Social media health activation campaigns

30,000 Facebook users watched

• ur ‘Back to

School’ campaign video, warning parents

• f the spike in

asthma attacks in September Our pollen campaign reached almost 300,000 on social channels

Increasing the reach of our Helpline nurses

Answering people with asthma’s questions on Facebook and Twitter Supporting people through the pilot

• f our 12-Week

Asthma Support Programme Appearing on instructional and advice videos

This video on cleaning your spacer has had 12,600 views on YouTube

Individual Giving

Joe Aldrich Direct Marketing Manager, Fundraising

INDIVIDUAL GIVING

CASH APPEALS & MAGAZINES RAFFLES & LOTTERY REGULAR GIVING STEWARDSHIP

Raising £1.8M a year

INDIVIDUAL GIVING –Cause led growth

*All figures up to the end of May 18

GROSS INCOME* £1.02M 5% growth year on year NET INCOME* £831K 9% growth year on year

INDIVIDUAL GIVING –Cause led growth

*All figures up to the end of May 18

2017/18 Gross Income Net Income 2016/17 XMAS APPEAL £48.6K £32.5K 35% net growth year on year SPRING RAFFLE £44.5K £17K 12% net growth year on year

95% 5%

2016/17

Offline Online

84% 16%

2017/18

Offline Online

98% 2%

2015/16

Offline Online

INDIVIDUAL GIVING – Lottery investment

*All figures up to the end of May 18

GROSS INCOME* £194K 47% growth year on year NET INCOME*

• £190K

900% increase in spend year on year

INDIVIDUAL GIVING – Lottery investment

*All figures up to the end of May 18

£32,000 £77,000

£0 £20,000 £40,000 £60,000 £80,000 £100,000

Online Phone

Gross Income through acquisition*

1500% 381%

0% 500% 1000% 1500% 2000%

Online Phone

Income % Increase Year on Year

The future is bright… the future is purple

1

2016 – 17 Financial Performance

Harriet Jones Director of Finance and Resources

Overall financial performance

£000’s 2014-15 2015-16 2016-17 Income 7,973 8,762 7,950 Expenditure 7,496 9,292* 7,139 Surplus/(deficit) 477 (530) 811 Investment gain / (loss) (229) 1,467 315 Net surplus 248 937 1,126

* Includes investment in Asthma UK Centre in Allergic Mechanisms of Asthma

Income

£000’s 2014-15 2015-16 2016-17 Individuals 2,404 2,430 2,108 Companies and Trusts 872 688 710 Community and Events 1,333 1,214 1,347 Legacies 3,059 3,697 3,041 Other Income 305 502 460 Gifts in Kind

• 231

284 Total 7,973 8,762 7,950

Income sources (gross)…..

… with costs of fundraising

Spend

£000’s 2014-15 2015-16 2016-17 Research 1,557 3,688 1,496 Improving care 1,312 905 798 Advice and support 2,293 2,507 2,579 Fundraising 2,290 2,171 2,266 Investment management 44 21

• Total expenditure

7,496 9,292 7,139

* Includes Governance

Reserves

Financial forecast

£000’s 2015-16 2016-17 2017-18 Income 8,762 7,984 8,239 Expenditure 9,292* 7,583 8,463 Surplus/(deficit) (530) 401 (224) Investment gain / (loss) 1,467

• Net surplus/(deficit)

937 401 (224)

* Includes investment in Asthma UK Centre in Allergic Mechanisms of Asthma

AGM Formal Business

John Tucker Chairman

AGM

▪ Formal AGM business ▪ Apologies ▪ Minutes from 2017 AGM ▪ Annual Report ▪ Auditors ▪ Trustee election (please be reminded only members can vote)

End